Latest News | Dr Reddy's Launches Migraine Management Device in Europe

New Delhi, Apr 10 (PTI) Dr Reddy's Laboratories on Wednesday said it has launched migraine management wearable device Nerivio in Germany through its step-down subsidiary Betapharm.

The launch marks the company's entry into digital therapeutics in Europe, the Hyderabad-based drug major said in a statement.

Also Read | Char Dham Yatra 2024 Registration: Kedarnath, Badrinath, Yamunotri, and Gangotri Temples To Open Doors for Devotees Soon, Know Dates and How To Register on registrationandtouristcare.uk.gov.

Nerivio is approved by the US Food and Drug Administration (USFDA), and is CE-mark certified in Europe.

Dr Reddy's launched Nerivio in India last year.

Also Read | BJP Foundation Day 2024 Date: Know the History and Significance of BJP Sthapna Diwas That Celebrates the Formation of the Bharatiya Janata Party.

Nerivio has had an encouraging start in India, with recommendations from neurologists in India and bringing relief to patients living with migraine, Dr Reddy's CEO of Branded Markets (India and Emerging Markets) MV Ramana said.

"We believe this product meets a genuine unmet clinical need among migraine patients, and has the potential to reduce pill burden in migraine," he added.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)